Table 2.
Characteristics of the Study Cohort Stratified by Sex
| Male (n = 141) | Female (n = 144) | p Value | |
|---|---|---|---|
| Genotype | |||
| MYBPC3 | 62 (44.0) | 61 (42.4) | 0.581 |
| MYH7 | 30 (21.3) | 39 (27.1) | |
| MYL2 | 3 (2.1) | 3 (2.1) | |
| TNNI3 | 17 (12.1) | 22 (15.3) | |
| TNNT2 | 21 (14.9) | 13 (9.0) | |
| TPM1 | 5 (3.5) | 4 (2.8) | |
| ACTC1 | 0 (0.0) | 1 (0.7) | |
| Multiple mutations | 3 (2.1) | 1 (0.7) | |
| Age, yrs | 12.6 (6.8–28.5) | 16.2 (6.7–35.6) | 0.257 |
| Follow-up duration, yrs | 7.7 (3.3–12.3) | 9.2 (4.6–13.6) | 0.027 |
| Abnormal ECG during follow-up | 44 (31.2) | 38 (26.4) | 0.369 |
| Hypertension | 5 (3.5) | 8 (5.6) | 0.416 |
| CMR | 71 (50.4) | 74 (51.4) | 0.861 |
| Diagnostic CMR, nondiagnostic echo | 10 (7.1) | 6 (4.2) | 0.283 |
Values are n (%) or median (interquartile range). p value is for comparison.
Abbreviations as in Table 1.